The variant, which is called B.1.1.529 and first identified in South Africa, has a spike protein that was dramatically different to the one in the original coronavirus that Covid-19 vaccines are based on. Scientists said lab studies were needed to assess the likelihood of the mutations resulting in greatly reduced vaccine efficacy.from World News Headlines, Latest International News, World Breaking News - Times of India
No comments:
Post a Comment